Explores functional silicones and bio-based silicone alternatives across diverse formulation systems. This category highlights key performance roles—slip, spreadability, barrier formation, conditioning, volatility, and sensory feel alongside naturally derived, silicone-like materials aligned with sustainability, regulatory, and clean-label expectations.
Currently, silicones play a central role in hair care formulations designed for detangling, smoothness, and conditioning. Unlike skin care, hair care relies heavily on surface lubrication and fiber alignment. As
Currently, silicone resins play a central role in formulations that require long wear, transfer resistance, and durable film formation. Unlike volatile silicones or elastomers, resins create cohesive, semi-continuous films that
Currently, silicone elastomers play a critical role in modern formulations that target soft-focus, blurring, and matte sensory effects. Unlike volatile silicones or linear polymers, elastomers function as three-dimensional networks that
Currently, dimethicone remains one of the most widely used silicone polymers in formulation. Unlike volatile silicones, dimethicone does not evaporate. Instead, it delivers long-lasting slip, cushioning, and skin or hair
Currently, regulatory risk around silicones no longer emerges only at the point of restriction. Instead, risk often appears much earlier through Substance of Very High Concern (SVHC) identification and restriction
Currently, silicone-free claims are appearing across formulations, packaging, and marketing materials at an accelerating pace. As a result, regulatory, legal, and technical teams are increasingly required to interpret what these
Currently, regulatory pressure is forcing formulators to move away from volatile cyclic silicones. As a result, cyclomethicone can no longer serve as a default sensory carrier in modern formulations. Instead,
Currently, the regulatory landscape for silicones is entering a decisive phase. As a result, cyclic siloxanes D4, D5, and D6 are no longer viewed as low-risk formulation workhorses. Instead, they